231 related articles for article (PubMed ID: 16512833)
1. Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
Ge Y; Zhan F; Barlogie B; Epstein J; Shaughnessy J; Yaccoby S
Br J Haematol; 2006 Apr; 133(1):83-92. PubMed ID: 16512833
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of fibroblast activation protein in patients with colon cancer.
Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
[TBL] [Abstract][Full Text] [Related]
3. Characterization of in vitro growth of multiple myeloma cells.
Zlei M; Egert S; Wider D; Ihorst G; Wäsch R; Engelhardt M
Exp Hematol; 2007 Oct; 35(10):1550-61. PubMed ID: 17889722
[TBL] [Abstract][Full Text] [Related]
4. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
[TBL] [Abstract][Full Text] [Related]
5. Expression of stromal cell markers in distinct compartments of human skin cancers.
Huber MA; Kraut N; Schweifer N; Dolznig H; Peter RU; Schubert RD; Scharffetter-Kochanek K; Pehamberger H; Garin-Chesa P
J Cutan Pathol; 2006 Feb; 33(2):145-55. PubMed ID: 16420310
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin.
Dolznig H; Schweifer N; Puri C; Kraut N; Rettig WJ; Kerjaschki D; Garin-Chesa P
Cancer Immun; 2005 Aug; 5():10. PubMed ID: 16076089
[TBL] [Abstract][Full Text] [Related]
7. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.
Cheng JD; Dunbrack RL; Valianou M; Rogatko A; Alpaugh RK; Weiner LM
Cancer Res; 2002 Aug; 62(16):4767-72. PubMed ID: 12183436
[TBL] [Abstract][Full Text] [Related]
8. Migration, adhesion and differentiation of malignant plasma cells in the 5T murine model of myeloma.
Asosingh K
Verh K Acad Geneeskd Belg; 2003; 65(2):127-34. PubMed ID: 12870183
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.
Pennisi A; Li X; Ling W; Khan S; Gaddy D; Suva LJ; Barlogie B; Shaughnessy JD; Aziz N; Yaccoby S
Br J Haematol; 2009 Jun; 145(6):775-87. PubMed ID: 19388929
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line.
Wang XM; Yu DM; McCaughan GW; Gorrell MD
Hepatology; 2005 Oct; 42(4):935-45. PubMed ID: 16175601
[TBL] [Abstract][Full Text] [Related]
11. Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
Nguyen AN; Stebbins EG; Henson M; O'Young G; Choi SJ; Quon D; Damm D; Reddy M; Ma JY; Haghnazari E; Kapoun AM; Medicherla S; Protter A; Schreiner GF; Kurihara N; Anderson J; Roodman GD; Navas TA; Higgins LS
Exp Cell Res; 2006 Jun; 312(10):1909-23. PubMed ID: 16600214
[TBL] [Abstract][Full Text] [Related]
12. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.
Nzeusseu Toukap A; Galant C; Theate I; Maudoux AL; Lories RJ; Houssiau FA; Lauwerys BR
Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140
[TBL] [Abstract][Full Text] [Related]
13. Role of interleukin 16 in multiple myeloma.
Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow.
Bae S; Park CW; Son HK; Ju HK; Paik D; Jeon CJ; Koh GY; Kim J; Kim H
Br J Haematol; 2008 Sep; 142(5):827-30. PubMed ID: 18510677
[TBL] [Abstract][Full Text] [Related]
15. Expression of the fibroblast activation protein during mouse embryo development.
Niedermeyer J; Garin-Chesa P; Kriz M; Hilberg F; Mueller E; Bamberger U; Rettig WJ; Schnapp A
Int J Dev Biol; 2001 Apr; 45(2):445-7. PubMed ID: 11330865
[TBL] [Abstract][Full Text] [Related]
16. CD74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis.
Levy MT; McCaughan GW; Abbott CA; Park JE; Cunningham AM; Müller E; Rettig WJ; Gorrell MD
Hepatology; 1999 Jun; 29(6):1768-78. PubMed ID: 10347120
[TBL] [Abstract][Full Text] [Related]
18. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
Rettig WJ; Garin-Chesa P; Healey JH; Su SL; Ozer HL; Schwab M; Albino AP; Old LJ
Cancer Res; 1993 Jul; 53(14):3327-35. PubMed ID: 8391923
[TBL] [Abstract][Full Text] [Related]
19. Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.
Chandesris MO; Soulier J; Labaume S; Crinquette A; Repellini L; Chemin K; Malphettes M; Fieschi C; Asli B; Uzunhan Y; Fermand JP; Bories JC; Arnulf B
Br J Haematol; 2007 Feb; 136(4):609-14. PubMed ID: 17223917
[TBL] [Abstract][Full Text] [Related]
20. Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade.
Stremenova J; Krepela E; Mares V; Trim J; Dbaly V; Marek J; Vanickova Z; Lisa V; Yea C; Sedo A
Int J Oncol; 2007 Oct; 31(4):785-92. PubMed ID: 17786309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
